RNA (1 g) was processed and hybridized onto the Human Exon 1.0 ST array (Affymetrix Inc., Santa Clara, CA, USA) according to the manufacturer's protocol as previously described [15]
The threshold level of 150 g/mL has been established based on the intake of therapeutic doses of pseudoephedrine, defined as a maximum daily dose of 240 mg pseudoephedrine taken either as: four daily oral administrations (one every 4-6 hours) of a 60 mg (or 2 x 30 mg) immediate release preparation (i.e
4c), an observation that is in agreement with our biochemical analyses (Table 1)
Frequently Asked Questions What is KLOW blend studied for in research
Here at Real Peptides, where our entire focus is on providing impeccably pure compounds for exacting research, we believe understanding this nuance is critical for achieving valid, reproducible results